Skip to content

Advertisement

BMC Medical Genetics

Research article
Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

MiR-146a rs2910164 G/C polymorphism and gastric cancer susceptibility: a meta-analysis

BMC Medical Genetics201415:117

https://doi.org/10.1186/s12881-014-0117-2

©  Xu et al.; licensee BioMed Central Ltd. 2014

Received: 27 March 2014

Accepted: 10 October 2014

Published: 20 October 2014

Open Peer Review reports

Abstract

Background

Evidence has shown that single nucleotide polymorphism located in pre-miRNA or mature microRNA may modify various biological processes and affect the processing of carcinogenesis. Published results about the association between miR-146a rs2910164 G/C polymorphism and human gastric cancer susceptibility are inconclusive. The aim of this study was to acquire a more precise effect of the association between the miR-146a rs2910164 polymorphism and gastric risk by meta-analysis.

Methods

Eligible genetic association studies were searched from PubMed, Web of Knowledge and Chinese Biomedicine Database on human subject. Quantitative data synthesis was conducted for the associations of miR-146a rs2910164 G/C polymorphism with susceptibility to gastric cancer.

Results

Nine eligible studies that included a total of 3,885 gastric cancer patients and 5,396 controls were identified in the present meta-analysis. The overall OR indicated a potential association between rs2910164 polymorphism and GC but the effect was not statistically significant (GG vs. CG/CC: OR = 1.076, 95% CI 0.925-1.251, P = 0.342). When stratifying for population, the result showed that miR-146a rs2910164 GG genotype was associated with increased gastric cancer risk among Chinese in recessive model (GG vs. CG/CC: OR = 1.171, 95% CI 1.050-1.306, P = 0.005). Besides, no significant difference was found in gender, smoking, location, metastasis of lymph node and Laurèn’s classification.

Conclusions

The present meta-analysis suggests an increased risk between miR-146a rs2910164 GG genotype and gastric cancer susceptibility in Chinese based on published literatures.

Keywords

microRNA-146aStomach neoplasmsPolymorphismMeta-analysis

Background

Gastric cancer (GC) is still one of the most common causes of cancer-related death worldwide despite an overall decrease in incidence over the past 10 years [1],[2]. It is generally accepted that individual genetic susceptibility has an important role in the pathogenesis of tumor including GC.

MicroRNAs (miRNAs/miR) are endogenous 18-24 nucleotide noncoding RNAs that could regulate gene expression and sequentially regulate various biological processes [3],[4]. Functional characterization of some microRNAs in cancer initiation and progression indicates that they might play a more important role in the pathogenesis of human cancers [5],[6]. The relationship between miRNA and cancer has been extensively studied since 2002, the first demonstration of a link between miRNA genes and cancer [7].

Studies have shown that the polymorphisms in pre-miRNA or mature microRNA may modify various biological processes by influencing the expression and/or target selection of microRNAs [8],[9]. Over the past decade, numerous studies identified genetic variants in the precursor or mature miRNA sequence of miR-146a rs2910164 (G > C), which have been reported to be associated with breast cancer and hepatocellular carcinoma [10],[11].

A number of studies were published to describe the association between miR-146a rs2910164 G/C polymorphism and cancer risk in recent years. A meta-analysis reported by Lian et al. [10] concluded that the CC homozygote of rs2910164 may contribute to breast cancer susceptibility among Europeans. Another meta-analysis demonstrated that there is no significant correlation between has-miR-146a rs2910164 polymorphism and breast cancer risk [12]. A HuGE meta-analysis in 2013 failed to find any significant association between rs2910164 polymorphism and the risk of breast cancer [13]. Based on systematic review, Chen et al. [14] reported that quality of evidence was low for rs2910164 SNP genetic association with lung cancer. Several meta-analyses pooled the association between rs2910164 polymorphism and cancer risk in general [15],[16]. Some meta-analysis reported the rs2910164 polymorphism and gastrointestinal cancer susceptibility [17]-[19].

However, published data on the association between miR-146a rs2910164 G/C polymorphism and human gastric cancer susceptibility are inconsistent and inconclusive. Therefore, we performed the present meta-analysis to quantitatively estimate the association of miR-146a G/C SNP with gastric cancer risks.

Methods

Literature search strategy

Electronic databases including PubMed, Web of Knowledge and Chinese Biomedicine Database (CBM) were searched for relevant studies conducted on human subject until July 2014. The following search keywords were used: 'gastric" or 'stomach', "neoplasm" OR "carcinoma" OR "cancer" OR "tumor" OR "adenocarcinoma" and "miR-146a OR "miRNA-146a" OR "microRNA-146a" OR "has-miR-146a". To further identify potentially relevant studies, the reference lists of articles identified in the initial search were also scanned manually. We directly contacted authors for related data that were unavailable in the original publications.

Inclusion and exclusion criteria

Studies were considered eligible if they met all of the following criteria: (1) explore the association between miR-146a polymorphism and human GC risk, (2) design as case-control studies, (3) identification of gastric cancer cases was confirmed histologically or pathologically. Studies were excluded based on any of the following reasons: (1) no sufficient data reported, (2) articles of letters, reviews, case reports, conference abstracts, editorials or expert opinion. If serial studies of the same population from the same research group were published, only the largest series were selected.

Data extraction

The final set of articles was assessed independently by two reviewers (Zhong Xu and Lingling Zhang) according to the inclusion criteria listed above. Disagreements were resolved by discussion. The following information was retrieved from each report: first author, publication year, study population, ethnicity, number of GC cases and controls, frequency of genotypes, and genotyping method.

Statistical analysis

Hardy-Weinberg equilibrium (HWE) status was examined by Pearson's goodness-of-fit χ2 test in each study (P <0.05 was considered as significant disequilibrium in the control group). The strength of the association between GC and the miR-146a rs2910164 polymorphism was assessed by calculating odds ratio (OR) with 95% confidence interval (CI). The pooled ORs were obtained from combination of single studies by homozygote comparison (GG vs. CC), heterozygote comparison (CG vs. CC), dominant and recessive models (CG/GG vs. CC, and GG vs. CG/CC), allele comparison (G vs. C), respectively. The analysis of heterogeneity between studies was determined by using the Cochrane's Q test and I 2-test (P <0.10 or I 2 > 50% was considered indicative of statistically heterogeneity) [20]. When there was no significant heterogeneity existing among studies, the pooled ORs estimate of each study was calculated by the fixed-effects model. Otherwise, the random-effects model was employed. Subgroup analyses were stratified by the study characteristic if there were enough reports. Sensitivity analysis was carried out by deleting one single study each time to examine the influence of individual data set on the pooled ORs. Publication bias was assessed by using the methods of Begg's funnel plots and Egger's test (P <0.05 was considered representative of statistically significant publication bias) [21],[22]. Statistical analyses performed by using the software Stata12.0 (Stata Corpotion, College Station, Texas).

Results

Studies selection and characteristics of the included studies

A total of 288 articles were identified from the PubMed, ISI and CBM database. The flow chart summarizes the literature review process as shown in Figure 1. A total of nine studies involving 3,885 GC cases and 5,396 controls were ultimately pooled for the present meta-analysis [23]-[31]. The characteristics of these studies are listed in Table 1. Among them, seven studies were performed in Asia (including patients from China, Japan and Korea), two studies in Europe (including patients from Greece, Germany, Lithuania and Latvia). Article by Okubo et al. [32] was excluded because of the duplication with another study [23]. All of the included articles were hospital-based case-control studies. The distribution of genotypes in the controls of all nine studies was in agreement with HWE.
Figure 1
Figure 1

Flow chart of Studies inclusion and exclusion.

Table 1

Characteristics of studies included in the meta-analysis

First author

Year

Location

Genotyping method

No. of cases

No. of controls

Cases

Controls

PHWEfor control

CC

CG

GG

CC

CG

GG

Okubo

2010

Japan

PCR-RFLP

552

697

236

243

73

254

322

121

0.2776

Zeng

2010

China

PCR-RFLP

304

304

89

153

62

119

132

53

0.1223

Hishida

2011

Japan

PCR-CTPP

583

1637

230

271

82

633

775

229

0.7381

Zhou F

2012

China

TaqMan MGB

1686

1895

286

822

578

393

951

551

0.6407

Zhou Y

2012

China

Locus-specific PCR

299

416

107

146

46

127

215

74

0.301

Ahn

2013

Korea

PCR-RFLP

461

447

159

231

71

164

221

62

0.3618

Dikeakos

2014

Greece

PCR-RFLP

163

480

105

45

13

307

149

24

0.2892

Kupcinskas

2014

Europe

Real Time-PCR

362

347

16

94

252

16

108

223

0.5311

Pu

2014

China

PCR-RFLP

197

513

65

96

36

143

274

96

0.0801

Quantitative data synthesis

The summary of this meta-analysis for the association between miR-146a rs2910164 G/C polymorphism and the susceptibility of gastric cancer were shown in Table 2. Overall, there was no significant association in genotype distribution between gastric cancer and control by combining the nine studies. The random-effects model was used to pool these results as statistically heterogeneity was observed between studies (P Q-test <0.1, I 2 > 50%). The pooled OR estimates of the meta-analyses were often greater than 1.00, indicating a potential association of rs2910164 polymorphism and GC although this effect was not statistically significant. For recessive model, as P Q-test <0.1 by heterogeneity analysis, also the random-effects model was used for analysis. As shown in Figure 2, there was no statistically increased risk of gastric cancer in recessive model when pooled the nine studies (recessive model, GG vs. CG/ CC: OR = 1.076, 95% CI 0.925-1.251, P = 0.342).
Table 2

Meta-analysis of miR-146a rs2910164 polymorphism with gastric cancer by population

Population

Comparison

No. of study

Test of association

Test of heterogeneity

OR (95% CI)

P

P(Q-test)

I 2

Asian

GG vs. CC

7

1.016(0.780, 1.324)

0.906

0.000

75.2%

CG vs. CC

0.998(0.847, 1.176)

0.982

0.014

62.2%

CG/GG vs. CC

1.005(0.830, 1.216)

0.962

0.001

75.1%

GG vs. CG/CC

1.025(0.861, 1.221)

0.779

0.036

55.6%

G vs. C

1.006(0.877, 1.153)

0.935

0.000

78.7%

European

GG vs. CC

2

1.331(0.802, 2.210)

0.269

0.512

0.0%

CG vs. CC

0.880(0.619, 1.253)

0.478

0.973

0.0%

CG/GG vs. CC

0.994(0.716, 1.380)

0.971

0.875

0.0%

GG vs. CG/CC

1.326(0.995, 1.767)

0.054

0.512

0.0%

G vs. C

1.146(0.937, 1.401)

0.184

0.608

0.0%

Overall

GG vs. CC

9

1.056(0.836, 1.334)

0.649

0.001

68.1%

CG vs. CC

0.984(0.853, 1.136)

0.830

0.037

51.3%

CG/GG vs. CC

1.005(0.852, 1.184)

0.956

0.002

66.9%

GG vs. CG/CC

1.076(0.925, 1.251)

0.342

0.052

48.0%

G vs. C

1.028(0.914, 1.155)

0.648

0.000

72.5%

Figure 2
Figure 2

Meta-analysis of miR-146a rs2910164 polymorphism and gastric cancer susceptibility for recessive model (GG vs. CG + CC).

However, as shown in Table 3 and Figure 3, when we performed subgroup analysis by location, the combined result showed that miR-146a rs2910164 GG genotype was associated with increased gastric cancer risk in China for recessive model (GG vs. CG/ CC: OR = 1.193, 95% CI 1.057-1.346, P = 0.004). In addition, interactions between miR-146a polymorphism and clinicopathological characters were also conducted when usable data obtained. No significant association between miR-146a genetic variant and gastric cancer risk were found in the stratified analysis by gender, smoking, location, metastasis of lymph node and Laurèn’s classification (Table 4).
Table 3

Meta-analysis of miR-146a rs2910164 polymorphism with gastric cancer in Chinese

Comparison

Test of association

Test of heterogeneity

OR (95% CI)

P

P(Q-test)

I 2

GG vs. CC

1.113(0.773, 1.604)

0.564

0.011

73.1%

CG vs. CC

1.045(0.783, 1.394)

0.766

0.012

72.8%

CG/GG vs. CC

1.065(0.779, 1.457)

0.692

0.002

79.4%

GG vs. CG/CC

1.193(1.057, 1.346)

0.004

0.201

35.1%

G vs. C

1.055(0.868, 1.283)

0.590

0.004

77.8%

Figure 3
Figure 3

Meta-analysis of miR-146a rs2910164 polymorphism and gastric cancer susceptibility in Chinese for recessive model (GG vs. CG + CC).

Table 4

Meta-analysis of rs2910164 polymorphism with GC by Clinicopathological characters

Parameters

Comparison

No. of study

Test of association

Test of heterogeneity

OR (95% CI)

P

P(Q-test)

I 2

Gender

CC vs. GG/CG

4

0.916 (0.691, 1.215)

0.542

0.201

37.7%

(Male vs. Female)

CC/CG vs. GG

4

0.939 (0.767, 1.148)

0.538

0.967

0.0%

Smoking (No vs. Yes)

CC vs. CG/GG

2

0.843 (0.554, 1.282)

0.425

0.315

0.9%

Site (Cardic vs. Non-Cardic)

CC vs. CG/GG

4

0.844 (0.593, 1.201)

0.346

0.382

0.0%

CC/CG vs. GG

4

0.897 (0.738, 1.090)

0.274

0.549

0.0%

Metastasis of lymph node (Negative vs. Positive)

CC vs. CG/GG

2

1.211(0.842, 1.742)

0.302

0.589

0.0%

Laurèn’s classification (Intestinal vs. Diffuse)

CC/CG vs. GG

4

0.961(0.807, 1.145)

0.658

0.655

0.0%

Sensitivity analysis and publication bias

We use one-way sensitivity analysis to evaluate the stability of the result in China [33]. In recessive model, the sensitivity analysis of pooled OR with 95%CI changed from 1.193(1.057, 1.346) to 0.995(0.786, 1.260) when omitting one study by Zhou F [26] (Figure 4). The corresponding pooled OR was not materially altered in other genetic models.
Figure 4
Figure 4

The influence of each study by omission of individual studies in China for recessive model.

Begg's funnel plot (Figure 5) and Egger's test (Figure 6) indicated no potential publication bias (P = 1.000 and 0.355, respectively). The funnel plots showed some asymmetry, which is probably due to the limited number of studies.
Figure 5
Figure 5

Begg's funnel plot with pseudo 95% confidence limits.

Figure 6
Figure 6

Egger's publication bias plot.

Discussion

MiR-146a has been shown to play an important role in cell proliferation, differentiation, apoptosis and tumorigenesis [34]-[37]. Study by Jazdzewski et al. [38] in 2008 has suggested that rs2910164, a common polymorphism in the pre-miR-146a sequence, could alter mature miR-146a expression and play a role in the tumorigenesis. In the past three years, a number of meta-analyses and review pooled the association between rs2910164 G > C polymorphism and cancer risk including gastrointestinal tumors broadly [15]-[19],[39]-[43]. Nine of them have evaluated the association between rs2910164 polymorphism and gastric cancer risk. With the same results, all of them concluded no significant association between rs2910164 polymorphism and gastric cancer.

Still why we performed this meta-analysis concerning the miR-146a polymorphism in gastric cancer susceptibility? Firstly, as shown in Table 5, the included studies were limited in all of these meta-analyses regarding gastric cancer. All of them excluded the study by Zhou Y et al. [27] because of absence data in the article. Among them, meta-analysis by Xu X et al. [19] included six researches [23]-[26],[28],[44] to evaluate the association between rs2910164 polymorphism and gastric cancer risk. However, one of the six included articles detected rs2910164 polymorphism from gastritis [44], not gastric cancer. Then, none of the nine meta-analyses evaluated the miR-146a rs2910164 G > C polymorphism and gastric cancer susceptibility in details. Moreover, it is general that esophageal cancer, liver cancer, gastric cancer, cervical cancer and other malignancies have too distinct molecular mechanisms and logically they do not seem to harbor a common polymorphism as a risk factor. Similarly, esophageal cancer, gastric cancer and colorectal cancer are not always consistent with each other in this term. Last but not least, an update is needed to evaluate the association between rs2910164 G > C polymorphism and gastric cancer risk. Therefore, we try to acquire a more precise assessment of the association between rs2910164 polymorphism and gastric risk.
Table 5

Meta-analyses of rs2910164 polymorphism and cancer risk (information about GC)

First author

Year

Included study about gastric cancer

  

[[24]]

[[25]]

[[26]]

[[28]]

[[23]]

[[44]]

Srivastava [15]

2012

√

√

√

 

√

 

Wang J [16]

2012

√

√

  

√

 

Wang F [17]

2012

√

√

  

√

 

Wu [18]

2013

√

√

  

√

 

Xu X [19]

2014

√

√

√

√

√

√

Qiu [40]

2011

√

√

  

√

 

He [41]

2012

√

√

√

 

√

 

Xu Y [42]

2013

√

√

√

 

√

 

Yin [43]

2013

√

√

√

 

√

 

Focused on rs2910164 SNP and gastric cancer, the present meta-analysis showed that the miR-146a GG genotype was associated with increased risk of gastric cancer in China subgroup in recessive model (pooled OR = 1.193). There were no significant differences in gender, smoking, location, metastasis of lymph node and Laurèn’s classification across genotypes.

Of the nine studies included, studies by Zeng et al. [24] and Zhou F et al. [26] describe distribution of genotype in gastric cancer by age. The former demonstrated that rs2910164 GC/GG genotype had a increased risk of gastric cancer especially in younger individuals aged (≤58 years), the later showed that GG genotype increased gastric cancer risk was more evident in younger subjects (≤65 years). Zhou Y et al. [27] did not find any differennt distribution in gastric cancer between different tumor size (<5 cm vs. ≥5 cm). In addition, Zeng et al. [24] reported no statistically significant association in the variant genotypes with tumor differentiation. Almost all of included studies were conducted in Asia except two studies were in Europe. The study by Kupcinskas et al. in Europe [30] analyzed gene polymorphisms of miR-146a in 995 subjects including Germany, Latvia and Lithuania. Data analysis showed that gene polymorphisms of miR-146a are not associated with risk of GC in Europe. Besides, no difference between diffuse and intestinal-type gastric cancer groups was found.

The results should be interpreted with carefulness because of several limitations. First, the limited patient numbers may have influence the outcomes. Although we conducted comprehensive literature research from multiple databases with no restriction in publication languages, dates, ethnicities and other factors, there were only a total of nine studies involving 3,885 gastric cancer cases and 5,396 controls for the present meta-analysis. The overall OR indicated a potential association between rs2910164 polymorphism and GC but the effect was not statistically significant. It is still hard to make a firm conclusion about the accuracy of association between miR-146a rs2910164 G > C polymorphism and gastric cancer susceptibility. Second, we use one-way sensitivity analysis to evaluate the stability of the meta-analysis and the result altered when omitting the study with the largest samples. Third, only a few included researches reported data of interactions between miR-146a polymorphism and clinicopathological characters in gastric cancer, and all of the pooled analysis of interactions was limited by small sample size and deficit of data.

Conclusion

In conclusion, the present meta-analysis suggests an increased risk between miR-146a rs2910164 GG genotype and gastric cancer susceptibility in Chinese based on published literatures. Further studies on a large scale may be needed to confirm the genetic susceptibility of miR-146a rs2910164 in gastric cancer.

Declarations

Acknowledgments

This paper was supported by the Funds of Guizhou Provincial Department of Science and Technology, No.qiankehe-J-2012-2240.

We thanks Master Yuan Zhou for provide the related original data.

Authors’ Affiliations

(1)
Department of Gastroenterology, Guizhou Provincial People's Hospital, The Affiliated People's Hospital of Guiyang Medical University, Guiyang, P.R. China
(2)
Department of Oncology, Guizhou Provincial People's Hospital, The Affiliated People's Hospital of Guiyang Medical University, Guiyang, P.R. China

References

  1. Siegel R, Naishadham D, Jemal A: Cancer statistics, 2013. CA Cancer J Clin. 2013, 63: 11-30. 10.3322/caac.21166.View ArticlePubMedGoogle Scholar
  2. Lin Y, Ueda J, Kikuchi S, Totsuka Y, Wei WQ, Qiao YL, Inoue M: Comparative epidemiology of gastric cancer between Japan and China. World J Gastroenterol. 2011, 17: 4421-4428. 10.3748/wjg.v17.i39.4421.View ArticlePubMedPubMed CentralGoogle Scholar
  3. Bartel DP, Chen CZ: Micromanagers of gene expression: the potentially widespread influence of metazoan microRNAs. Nat Rev Genet. 2004, 5: 396-400. 10.1038/nrg1328.View ArticlePubMedGoogle Scholar
  4. Bartel DP: MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004, 116: 281-297. 10.1016/S0092-8674(04)00045-5.View ArticlePubMedGoogle Scholar
  5. Esquela-Kerscher A, Slack FJ: Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer. 2006, 6: 259-269. 10.1038/nrc1840.View ArticlePubMedGoogle Scholar
  6. Costinean S, Zanesi N, Pekarsky Y, Tili E, Volinia S, Heerema N, Croce CM: Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in E(mu)-miR155 transgenic mice. Proc Natl Acad Sci U S A. 2006, 103: 7024-7029. 10.1073/pnas.0602266103.View ArticlePubMedPubMed CentralGoogle Scholar
  7. Calin GA, Dumitru CD, Shimizu M, Bichi R, Zupo S, Noch E, Aldler H, Rattan S, Keating M, Rai K, Rassenti L, Kipps T, Negrini M, Bullrich F, Croce CM: Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A. 2002, 99: 15524-15529. 10.1073/pnas.242606799.View ArticlePubMedPubMed CentralGoogle Scholar
  8. Saunders MA, Liang H, Li WH: Human polymorphism at microRNAs and microRNA target sites. Proc Natl Acad Sci U S A. 2007, 104: 3300-3305. 10.1073/pnas.0611347104.View ArticlePubMedPubMed CentralGoogle Scholar
  9. Iwai N, Naraba H: Polymorphisms in human pre-miRNAs. Biochem Biophys Res Commun. 2005, 331: 1439-1444. 10.1016/j.bbrc.2005.04.051.View ArticlePubMedGoogle Scholar
  10. Lian H, Wang L, Zhang J: Increased risk of breast cancer associated with CC genotype of Has-miR-146a Rs2910164 polymorphism in Europeans. PLoS One. 2012, 7: e31615-10.1371/journal.pone.0031615.View ArticlePubMedPubMed CentralGoogle Scholar
  11. Xu Y, Li L, Xiang X, Wang H, Cai W, Xie J, Han Y, Bao S, Xie Q: Three common functional polymorphisms in microRNA encoding genes in the susceptibility to hepatocellular carcinoma: a systematic review and meta-analysis. Gene. 2013, 527: 584-593. 10.1016/j.gene.2013.05.085.View ArticlePubMedGoogle Scholar
  12. Gao LB, Bai P, Pan XM, Jia J, Li LJ, Liang WB, Tang M, Zhang LS, Wei YG, Zhang L: The association between two polymorphisms in pre-miRNAs and breast cancer risk: a meta-analysis. Breast Cancer Res Treat. 2011, 125: 571-574. 10.1007/s10549-010-0993-x.View ArticlePubMedGoogle Scholar
  13. Chen QH, Wang QB, Zhang B: Ethnicity modifies the association between functional microRNA polymorphisms and breast cancer risk: a HuGE meta-analysis. Tumour Biol. 2013, 35: 529-543. 10.1007/s13277-013-1074-7.View ArticlePubMedGoogle Scholar
  14. Chen Z, Xu L, Ye X, Shen S, Li Z, Niu X, Lu S: Polymorphisms of microRNA sequences or binding sites and lung cancer: a meta-analysis and systematic review. PLoS One. 2013, 8: e61008-10.1371/journal.pone.0061008.View ArticlePubMedPubMed CentralGoogle Scholar
  15. Srivastava K, Srivastava A: Comprehensive review of genetic association studies and meta-analyses on miRNA polymorphisms and cancer risk. PLoS One. 2012, 7: e50966-10.1371/journal.pone.0050966.View ArticlePubMedPubMed CentralGoogle Scholar
  16. Wang J, Wang Q, Liu H, Shao N, Tan B, Zhang G, Wang K, Jia Y, Ma W, Wang N, Cheng Y: The association of miR-146a rs2910164 and miR-196a2 rs11614913 polymorphisms with cancer risk: a meta-analysis of 32 studies. Mutagenesis. 2012, 27: 779-788. 10.1093/mutage/ges052.View ArticlePubMedGoogle Scholar
  17. Wang F, Sun G, Zou Y, Fan L, Song B: Lack of association of miR-146a rs2910164 polymorphism with gastrointestinal cancers: evidence from 10206 subjects. PLoS One. 2012, 7: e39623-10.1371/journal.pone.0039623.View ArticlePubMedPubMed CentralGoogle Scholar
  18. Wu D, Wang F, Dai WQ, He L, Lu J, Xu L, Guo CY: The miR-146a rs2910164 G > C polymorphism and susceptibility to digestive cancer in Chinese. Asian Pac J Cancer Prev. 2013, 14: 399-403. 10.7314/APJCP.2013.14.1.399.View ArticlePubMedGoogle Scholar
  19. Xu X, Yang X, Ru G, Wu Y, Zhang S, Xing C, Wu Y, Cao J: miR-146a gene polymorphism rs2910164 and the risk of digestive tumors: a meta-analysis of 21 case-control studies. Oncol Rep. 2014, 31: 472-479.PubMedGoogle Scholar
  20. Higgins JP, Thompson SG: Quantifying heterogeneity in a meta-analysis. Stat Med. 2002, 21: 1539-1558. 10.1002/sim.1186.View ArticlePubMedGoogle Scholar
  21. Egger M, Davey Smith G, Schneider M, Minder C: Bias in meta-analysis detected by a simple, graphical test. BMJ (Clinical research ed). 1997, 315: 629-634. 10.1136/bmj.315.7109.629.View ArticleGoogle Scholar
  22. Begg CB, Mazumdar M: Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994, 50: 1088-1101. 10.2307/2533446.View ArticlePubMedGoogle Scholar
  23. Okubo M, Tahara T, Shibata T, Yamashita H, Nakamura M, Yoshioka D, Yonemura J, Ishizuka T, Arisawa T, Hirata I: Association between common genetic variants in pre-microRNAs and gastric cancer risk in Japanese population. Helicobacter. 2010, 15: 524-531. 10.1111/j.1523-5378.2010.00806.x.View ArticlePubMedGoogle Scholar
  24. Zeng Y, Sun QM, Liu NN, Dong GH, Chen J, Yang L, Wang B: Correlation between pre-miR-146a C/G polymorphism and gastric cancer risk in Chinese population. World J Gastroenterol. 2010, 16: 3578-3583. 10.3748/wjg.v16.i28.3578.View ArticlePubMedPubMed CentralGoogle Scholar
  25. Hishida A, Matsuo K, Goto Y, Naito M, Wakai K, Tajima K, Hamajima N: Combined effect of miR-146a rs2910164 G/C polymorphism and Toll-like receptor 4 +3725 G/C polymorphism on the risk of severe gastric atrophy in Japanese. Dig Dis Sci. 2011, 56: 1131-1137. 10.1007/s10620-010-1376-1.View ArticlePubMedGoogle Scholar
  26. Zhou F, Zhu H, Luo D, Wang M, Dong X, Hong Y, Lu B, Zhou Y, Zhou J, Zhang Z, Gong W: A functional polymorphism in Pre-miR-146a is associated with susceptibility to gastric cancer in a Chinese population. DNA Cell Biol. 2012, 31: 1290-1295. 10.1089/dna.2011.1596.View ArticlePubMedGoogle Scholar
  27. Zhou Y, Du WD, Chen G, Ruan J, Xu S, Zhou FS, Zuo XB, Lv ZJ, Zhang XJ: Association analysis of genetic variants in microRNA networks and gastric cancer risk in a Chinese Han population. J Cancer Res Clin Oncol. 2012, 138: 939-945. 10.1007/s00432-012-1164-8.View ArticlePubMedGoogle Scholar
  28. Ahn DH, Rah H, Choi YK, Jeon YJ, Min KT, Kwack K, Hong SP, Hwang SG, Kim NK: Association of the miR-146aC > G, miR-149T > C, miR-196a2T > C, and miR-499A > G polymorphisms with gastric cancer risk and survival in the Korean population. Mol Carcinog. 2013, 52: 39-51. 10.1002/mc.21962.View ArticleGoogle Scholar
  29. Dikeakos P, Theodoropoulos G, Rizos S, Tzanakis N, Zografos G, Gazouli M: Association of the miR-146aC > G, miR-149T > C, and miR-196a2T > C polymorphisms with gastric cancer risk and survival in the Greek population. Mol Biol Rep. 2014, 41: 1075-1080. 10.1007/s11033-013-2953-0.View ArticlePubMedGoogle Scholar
  30. Kupcinskas J, Wex T, Link A, Leja M, Bruzaite I, Steponaitiene R, Juzenas S, Gyvyte U, Ivanauskas A, Ancans G, Petrenkiene V, Skieceviciene J, Kupcinskas L, Malfertheiner P: Gene polymorphisms of micrornas in helicobacter pylori-induced high risk atrophic gastritis and gastric cancer. PLoS One. 2014, 9: e87467-10.1371/journal.pone.0087467.View ArticlePubMedPubMed CentralGoogle Scholar
  31. Pu J-Y, Dong W, Zhang L, Liang W-B, Yang Y, Lv M-L: No association between single nucleotide polymorphisms in pre-mirnas and the risk of gastric cancer in Chinese population. Iranian Journal of Basic Medical Sciences. 2014, 17: 128-133.PubMedPubMed CentralGoogle Scholar
  32. Okubo M, Tahara T, Shibata T, Yamashita H, Nakamura M, Yoshioka D, Yonemura J, Kamiya Y, Ishizuka T, Nakagawa Y, Nagasaka M, Iwata M, Arisawa T, Hirata I: Association between common genetic variants in pre-microRNAs and the clinicopathological characteristics and survival of gastric cancer patients. Experimental and Therapeutic Medicine. 2010, 1: 1035-1040.PubMedPubMed CentralGoogle Scholar
  33. Tobias A: Assessing the influence of a single study in the meta-analysis estimate. Stata Tech Bull. 1999, 8: 15-17.Google Scholar
  34. Hou Z, Xie L, Yu L, Qian X, Liu B: MicroRNA-146a is down-regulated in gastric cancer and regulates cell proliferation and apoptosis. Med Oncol. 2012, 29: 886-892. 10.1007/s12032-011-9862-7.View ArticlePubMedGoogle Scholar
  35. Paik JH, Jang JY, Jeon YK, Kim WY, Kim TM, Heo DS, Kim CW: MicroRNA-146a downregulates NFkappaB activity via targeting TRAF6 and functions as a tumor suppressor having strong prognostic implications in NK/T cell lymphoma. Clin Cancer Res. 2011, 17: 4761-4771. 10.1158/1078-0432.CCR-11-0494.View ArticlePubMedGoogle Scholar
  36. Bhaumik D, Scott GK, Schokrpur S, Patil CK, Campisi J, Benz CC: Expression of microRNA-146 suppresses NF-kappaB activity with reduction of metastatic potential in breast cancer cells. Oncogene. 2008, 27: 5643-5647. 10.1038/onc.2008.171.View ArticlePubMedPubMed CentralGoogle Scholar
  37. Hurst DR, Edmonds MD, Scott GK, Benz CC, Vaidya KS, Welch DR: Breast cancer metastasis suppressor 1 up-regulates miR-146, which suppresses breast cancer metastasis. Cancer Res. 2009, 69: 1279-1283. 10.1158/0008-5472.CAN-08-3559.View ArticlePubMedPubMed CentralGoogle Scholar
  38. Jazdzewski K, Murray EL, Franssila K, Jarzab B, Schoenberg DR, de la Chapelle A: Common SNP in pre-miR-146a decreases mature miR expression and predisposes to papillary thyroid carcinoma. Proc Natl Acad Sci U S A. 2008, 105: 7269-7274. 10.1073/pnas.0802682105.View ArticlePubMedPubMed CentralGoogle Scholar
  39. Xu W, Xu J, Liu S, Chen B, Wang X, Li Y, Qian Y, Zhao W, Wu J: Effects of common polymorphisms rs11614913 in miR-196a2 and rs2910164 in miR-146a on cancer susceptibility: a meta-analysis. PLoS One. 2011, 6: e20471-10.1371/journal.pone.0020471.View ArticlePubMedPubMed CentralGoogle Scholar
  40. Qiu LX, He J, Wang MY, Zhang RX, Shi TY, Zhu ML, Mao C, Sun S, Lv FF, Zheng CL, Zhu XD: The association between common genetic variant of microRNA-146a and cancer susceptibility. Cytokine. 2011, 56: 695-698. 10.1016/j.cyto.2011.09.001.View ArticlePubMedGoogle Scholar
  41. He B, Pan Y, Cho WC, Xu Y, Gu L, Nie Z, Chen L, Song G, Gao T, Li R, Wang S: The association between four genetic variants in microRNAs (rs11614913, rs2910164, rs3746444, rs2292832) and cancer risk: evidence from published studies. PLoS One. 2012, 7: e49032-10.1371/journal.pone.0049032.View ArticlePubMedPubMed CentralGoogle Scholar
  42. Xu Y, Gu L, Pan Y, Li R, Gao T, Song G, Nie Z, Chen L, Wang S, He B: Different effects of three polymorphisms in MicroRNAs on cancer risk in Asian population: evidence from published literatures. PLoS One. 2013, 8: e65123-10.1371/journal.pone.0065123.View ArticlePubMedPubMed CentralGoogle Scholar
  43. Yin Z, Yan L, Cui Z, Li X, Ren Y, Zhou B: Effects of common polymorphisms rs2910164 in miR-146a and rs3746444 in miR-499 on cancer susceptibility: a meta-analysis. Mol Biol Rep. 2013, 40: 3003-3013. 10.1007/s11033-012-2372-7.View ArticlePubMedGoogle Scholar
  44. Song MY, Su HJ, Zhang L, Ma JL, Li JY, Pan KF, You WC: Genetic polymorphisms of miR-146a and miR-27a, H. pylori infection, and risk of gastric lesions in a Chinese population. PLoS One. 2013, 8: e61250-10.1371/journal.pone.0061250.View ArticlePubMedPubMed CentralGoogle Scholar

Copyright

© Xu et al.; licensee BioMed Central Ltd. 2014

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Advertisement

BMC Medical Genetics

ISSN: 1471-2350

Contact us